Using Chemoembolization to Help Liver Transplant Patients
Author Information
Author(s): Antoine Bouchard-Fortier, Réal Lapointe, Pierre Perreault, Louis Bouchard, Gilles Pomier-Layrargues
Primary Institution: Centre Hospitalier de l'Université de Montréal
Hypothesis
Can transcatheter arterial chemoembolization (TACE) effectively bridge the waiting time for liver transplantation in cirrhotic patients with hepatocellular carcinoma?
Conclusion
TACE is useful as a bridge to liver transplantation in selected cirrhotic patients with hepatocellular carcinoma.
Supporting Evidence
- 48 TACE procedures were performed on 30 patients.
- Complete necrosis of the tumor was observed in 11 patients.
- Partial necrosis was observed in 15 patients.
- 4 patients were removed from the transplant list due to tumor progression or liver failure.
Takeaway
Doctors used a treatment called TACE to help patients with liver cancer get ready for a liver transplant. It worked well for many of them.
Methodology
TACE was performed on 30 cirrhotic patients with hepatocellular carcinoma, and their responses were monitored through imaging and follow-up.
Potential Biases
Potential bias in patient selection and evaluation of tumor response.
Limitations
The study had a small sample size and was highly selective, which may limit the generalizability of the results.
Participant Demographics
30 patients (23 men, 7 women; mean age 55 years; 22 Caucasians, 4 Asians, 3 South Americans, 1 African).
Statistical Information
P-Value
p=0.051
Confidence Interval
95% CI (1.53–26.18)
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website